Literature DB >> 11790932

Molecular mechanisms underlying the long QT syndrome.

Robert Dumaine1, Charles Antzelevitch.   

Abstract

Recent studies of the molecular basis of the long QT syndrome (LQTS) have advanced our understanding of the mechanisms responsible for the abnormal prolongation of ventricular repolarization and revealed associations between LQTS and other primary electrical diseases of the heart such as Brugada syndrome. The role of DNA single nucleotide polymorphisms in acquired LQTS and differences between the Romano-Ward and Jervell-Lange-Nielsen forms of congenital LQTS are gradually coming into focus. In this brief review, our goal is to summarize the molecular mechanisms proposed to underlie the susceptibility to arrhythmias in LQTS and discuss the direction of current and future research.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11790932     DOI: 10.1097/00001573-200201000-00006

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  5 in total

1.  Drug-Induced Arrhythmias, Precision Medicine, and Small Data.

Authors:  Glenn I Fishman
Journal:  Circ Arrhythm Electrophysiol       Date:  2017-04

2.  Characterization of novel KCNH2 mutations in type 2 long QT syndrome manifesting as seizures.

Authors:  Dagmar I Keller; Julie Grenier; Georges Christé; Frédérique Dubouloz; Stefan Osswald; Marijke Brink; Eckhard Ficker; Mohamed Chahine
Journal:  Can J Cardiol       Date:  2009-08       Impact factor: 5.223

Review 3.  [Long QT syndrome and anaesthesia].

Authors:  S Rasche; T Koch; M Hübler
Journal:  Anaesthesist       Date:  2006-03       Impact factor: 1.041

4.  Differences between ion binding to eag and HERG voltage sensors contribute to differential regulation of activation and deactivation gating.

Authors:  Meng Chin A Lin; Diane M Papazian
Journal:  Channels (Austin)       Date:  2008-02-19       Impact factor: 2.581

Review 5.  Inherited cardiac arrhythmias.

Authors:  Peter J Schwartz; Michael J Ackerman; Charles Antzelevitch; Connie R Bezzina; Martin Borggrefe; Bettina F Cuneo; Arthur A M Wilde
Journal:  Nat Rev Dis Primers       Date:  2020-07-16       Impact factor: 52.329

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.